A Valentine's card exchanged reminded columnist Halsey Blocher that disabled people also deserve opportunities to serve ...
The U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of Evrysdi (risdiplam), an approved oral ...
Columnist Helen Baldwin reflects on a quarter century of changes in the SMA community and honors the memory of two ...
Spinraza treatment does not lead to significant kidney dysfunction in SMA patients with types 1 and 2, a safety and efficacy ...
Liver issues, including a buildup of fat in the liver, occur before the onset of neuromuscular disease, per a study in a ...
For columnist Alyssa Silva, advances in the development of SMA treatments have felt like glimmers of miracles.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results